TrialDox Blog – Accelerating clinical trials…

Archive for the ‘phase IV’ tag

Chart of the Day: Probability of success of clinical trials

without comments

For pharma, this is the curve that needs to be re-shaped:

Probability of success of trials

Source: Morgan Stanley

Written by admin

February 19th, 2010 at 10:28 am

Chart of the Day: Where is clinical research happening (therapeutic areas)?

without comments

Most clinical research is happening in oncology, CNS, and cardiovascular:

Clinical research by therapeutic area

Source: Company research via Barclays Capital

Written by admin

February 15th, 2010 at 10:20 am

Chart of the Day: Where is the clinical research happening (phase)?

without comments

Pre-phase II R&D accounts for about 35% of total R&D spending:

Research by phase

Source: PhRMA, 2009

Written by admin

February 12th, 2010 at 10:17 am

Chart of the Day: How do clinical trial phases differ?

without comments

One unique aspect of the drug development pipeline (see previous Chart of the Day) is that there is a series of clinical trials conducted by pharmaceutical companies and CROs in a phased approach. University of Pittsburgh has compiled a convenient summary of each phase to better understand the differences among clinical trial phases (link here):

Phases of Clinical Research

Written by admin

November 16th, 2009 at 8:26 pm

Chart of the day: Drug approval pipeline

with one comment

Always nice to see helpful illustrations of the time required and probability of success of compounds receiving FDA approval:

Drug development pipeline

It’s a reminder of TrialDox’s mission to minimize the time to complete clinical studies and get safe and effective products to the market faster.

Written by admin

November 15th, 2009 at 12:07 am